-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials: Poster III

Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Adult, antibodies, Biological, Follicular Lymphoma, Leukemia, bioengineering, bone marrow, Diseases, Lymphoma (any), Combinations, Mantle Cell Lymphoma, Therapies, Adverse Events, checkpoint inhibitors, CNS Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, DLBCL, enzyme inhibitors, T-Cell Lymphoma, Technology and Procedures, immunotherapy, infusion, Lymphoid Malignancies, Study Population, Clinically relevant, NK cells, transplantation, TKI
Monday, December 7, 2020: 7:00 AM-3:30 PM

Tae Min Kim, MD, PhD1*, Nehal Lakhani, MD, PhD2*, Justin Gainor, MD3*, Manali Kamdar, MD4, Philip Fanning, PhD5*, Pierre Squifflet, MSc6*, Feng Jin, PhD5*, Alison J. Forgie, PhD5*, Hong Wan, PhD5*, Jaume Pons, PhD5*, Sophia S Randolph, MD, PhD5 and Won Seog Kim, MD, PhD7*

1Seoul National University Hospital, Seoul, South Korea
2START Midwest, Grand Rapids, MI
3Massachusetts General Hospital Cancer Center, Boston, MA
4Division of Hematology, Hematologic Malignancies and Stem Cell Transplantation, University of Colorado Cancer Center, Denver, CO
5ALX Oncology Inc., Burlingame, CA
6International Drug Development Institute, Ottignies Louvain-la-Neuve, BEL
7Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)

Dok Hyun Yoon1*, Youngil Koh, MD, PhD2, Heesook Park3*, Yu kyeong Hwang4* and Won Seog Kim5*

1Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
2Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea
3Development Unit, Cell Therapy Research Center, GCLabCell, Yongin-Si, Gyeonggi-Do, South Korea
4Cell Therapy Research Center, GCLabCell, Yongin, Korea, Republic of (South)
5Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)

Khe Hoang-Xuan, MD, PhD1*, Roch Houot, MD, PhD2*, Carole Soussain, MD, PhD3, Marie Blonski, MD4*, Anna Schmitt, MD5*, Vincent Delwail, MD6*, Gandhi Laurent Damaj, MD, PhD7, Herve Ghesquieres, MD, PhD8*, Frédéric Peyrade, MD9*, Adrian Tempescul, MD10*, Julie Abraham, MD11*, Philippe Agape, MD12*, Guido Ahle, MD13*, Nathalie Baize, MD14*, Pierre Bories, MD15*, Chantal Campello, MD16*, Emmanuel Gyan, MD, PhD17, Fabrice Jardin, MD, PhD18*, Philippe Rey, MD19*, Sylvain Choquet, MD20*, Caroline Houillier, MD21*, Nathalie Cassoux, MD, PhD22*, Valerie Touitou, MD, PhD23*, Nadine Martin-Duverneuil, MD24*, Frederic Legrand25*, Assia Lamrani-Ghaouti26*, Ophelie Querel26*, Natalie Hoog Labouret, MD25*, Clotilde Simon26*, Sylvie Chevret, MD, PhD27* and Christophe Massard, MD, PhD28*

1Department of Neurooncology, La Pitie Salpetriere Hospital, Assistance Publique Hopitaux de Paris, Paris, France
2Hematology Department, CHU Rennes, Rennes, France
3Hematology Department, Rene Huguenin Hospital, Institut Curie, Saint-Cloud, France
4CHU Nancy, Nancy, France
5Institut Bergonié, Bordeaux, France
6CIC 802 INSERM, CHU Poitiers, Poitiers, FRA
7CHU de Caen Normandie, Normandie, France
8Department of Hematology, Centre Hospitalier Lyon-Sud, University Claude Bernard Lyon 1, Pierre Benite, France
9Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France
10Department of Hematology, University Hospital of Brest, Brest, France
11Clinical Hematology Service, CHU Limoges, Limoges, FRA
12Hematology Department, ICO Rene Gauducheau, Saint-Herblain, France
13Neurology Department, CH Colmar, Colmar, France
14CHU Angers, Angers, France
15Hematology Laboratory, Onco-occitanie Network, Toulouse University Institute of Cancer-Oncopole, Toulouse, France
16CHU Marseille, Neurooncology Unit ,Hôpital La Timone, Marseille, France
17Centre Hospitalier Universitaire, Service D'Hemaologie Et Therapie Cellulaire, Tours Cedex, France
18Department of Hematology, Centre Henri Becquerel, Rouen, France
19Hematology, Centre Leon Berard, Lyon, France
20Hematology Department, La Pitie Salpetriere Hospital, Assistance Publique Hopitaux de Paris, Paris, France
21LOC network, La Pitie Salpetriere Hospital, Assistance Publique Hopitaux de Paris, Paris, France
22Institut Curie, Paris, FRA
23Department of Ophtalmology, AP-HP, HôPital Pitié-Salpêtrière, Paris, FRA
24Department of Neuroradiology, APHP, CHU Pitié-Salpêtrière, Paris, France
25Inca, Boulogne Billancourt, France
26Unicancer, Paris, France
27APHP, HOPITAL St LOUIS, PARIS, France
28Gustave Roussy Cancer Campus, Villejuif, France

Beatriz Rey Búa1*, Ana Jiménez Ubieto, MD PhD2*, Jose Javier Sanchez Blanco3*, Pau Abrisqueta, MD, PhD4*, Antonio Gutierrez5*, Angel Ramirez Payer6*, Eva Giné, MD, PhD7, Izaskun Cebeiro Sr.8*, Maria Jose Terol9*, Fatima De la Cruz, MD10*, Rafael Andreu11*, María José Ramírez Sánchez12*, Adolfo de la Fuente13*, Ma Cruz Viguria14*, Maria Jesús Peñarrubia15*, Carlos Grande16*, Dolores Caballero, MD, PhD17 and Alejandro Martin Garcia-Sancho, MD, PhD18*

1Hospital Universitario de Salamanca Hematología. Instituto de investigación biomédica de Salamanca (IBSAL), Salamanca, Spain
2Hematología y Hemoterapia, Hospital 12 de Octubre, Madrid, Spain
3Hospital Morales Messeguer, Murcia, Spain
4Department of Hematology, University Hospital Vall d’Hebron, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron Barcelona Hospital Campus, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain
5Hematology Department, Son Espases University Hospital/IdISBa, Palma, Spain
6H. C. Asturias, Oviedo, Asturias, Spain
7Hematology Department, Hospital Clinic of Barcelona. IDIBAPS. University of Barcelona, Barcelona, Spain
8H. de Donostia, Donostia, Donostia, Spain
9Hospital Clínico Universitari de València, Valencia, Spain
10Hospital Universitario Virgen del Rocio, Seville, ESP
11Hospital Universitario La Fe de Valencia, VALENCIA, ESP
12H. Especialidades Jerez de la Frontera, Jerez, Jerez, Spain
13MD Anderson Cancer Center, Madrid, Spain
14Complejo Hospitalario de Navarra, Navarra, Spain
15Hospital Clinico Universitario de Valladolid, Valladolid, Spain
16Hospital 12 De Octubre, Madrid, ESP
17Department of Hematology, Hospitalario Universitario de Salamanca (HUS/IBSAL) and CIBERONC, Salamanca, Spain
18Department of Hematology, Hospital Clínico Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain

Laurie H. Sehn, MD, MPH1, Mark Hertzberg2*, Stephen Opat, MBBS (Hons), FRACP, FRCPA3, Alex F. Herrera, MD4, Sarit E Assouline, MD, MSc5, Christopher Flowers, MD, MS6, Tae Min Kim, MD, PhD7*, Andrew McMillan8, Muhit Ozcan, MD9, Violaine Safar10*, Gilles Salles, MD, PhD10, Lisa Musick, PharmD, BCPS11*, Jamie Hirata12, YiMeng Chang13*, Grace Ku12* and Matthew J Matasar, MD, MS14

1BC Cancer Centre for Lymphoid Cancer, University of British Columbia, vancouver, BC, Canada
2Prince of Wales Hospital and University of NSW, Sydney, Australia
3Clinical Haematology, Monash Health and Monash University, Clayton, Australia
4City of Hope, Duarte, CA
5Division of Hematology, Sir Mortimer B. Davis-Jewish General Hospital, Department of Oncology, McGill University, Montreal, QC, Canada
6MD Anderson Cancer Center, Houston, TX
7Seoul National University Hospital, Seoul, South Korea
8Center for Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
9Ankara University School of Medicine, Ankara, Turkey
10Centre Hospitalier Lyon-Sud, Lyon, France
11Genentech, South San Francisco, CA
12Genentech, Inc., South San Francisco, CA
13F. Hoffmann-La Roche Ltd, Mississauga, ON, Canada
14Department of Medicine, Lymphoma Service, Memorial Sloan-Kettering Cancer Center/New York Presbyterian, New York, NY

Kami J. Maddocks, MD1, Johannes Duell, MD2*, Eva González-Barca, MD, PhD3*, Wojciech Jurczak4*, Anna Marina Liberati, MD5, Sven de Vos, MD, PhD6, Zsolt Nagy, MD, PhD7*, Aleš Obr, MD, PhD8*, Gianluca Gaidano9, Pau Abrisqueta, MD, PhD10*, Marc André, MD11*, Martin Dreyling, MD12, Tobias F Menne, MD, PhD, FRCPath13*, Maren Dirnberger-Hertweck, PhD14*, Johannes Weirather, PhD14*, Sumeet Ambarkhane, MD, MBBS14 and Gilles Salles, MD, PhD15

1Department of Internal Medicine, Arthur G James Comprehensive Cancer Center, Ohio State University Wexner Medical Center, Columbus, OH
2Medizinische Klinik und Poliklinik II, Universitätsklinik Würzburg, Würzburg, Germany
3Department of Hematology, Institut Catalá d’Oncologia (ICO), Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, Barcelona, Spain
4Department of Clinical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Kraków, Poland
5Università degli Studi di Perugia, Azienda Ospedaliera Santa Maria di Terni, Terni, Italy
6Department of Medicine, Ronald Reagan UCLA Medical Center, Santa Monica, CA
71st Department of Internal Medicine, Semmelweis University, Budapest, Hungary
8Department of Hemato-Oncology, Palacký University and University Hospital, Olomouc, Czech Republic
9Division of Hematology, Department of Translational Medicine, University of Piemonte Orientale Amedeo Avogadro, Novara, Italy
10Department of Hematology, Vall d’Hebron Institute of Oncology (VHIO), Vall d’Hebron University Hospital, Barcelona, Spain
11Department of Haematology, Université Catholique de Louvain, CHU UCL Namur, Yvoir, Belgium
12LMU Hospital, Munich, Germany
13Department of Haematology, Freeman Hospital, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, United Kingdom
14MorphoSys AG, Planegg, Germany
15Hématologie, Hospices Civils de Lyon and Université de Lyon, Lyon, France

Jie Wang, MD1, Adam S. Asch, MD2, Nada Hamad, MBBS, BSc, MSc, FRACP FRCPA3, Andrew Weickhardt, MBBS(Hons) FRACP DMedSc4*, Monika Tomaszewska-Kiecana5*, Monika Dlugosz-Danecka, MD, PhD6*, Halyna Pylypenko, MD7*, Shakeela Bahadur, MD8*, Susanna Ulahannan, MD, MMed9*, Janine Koucheki10*, Jichao Sun, PhD10*, Hua Li10*, Francine Chen, MD11*, Xiaoyu Zhang10*, John Muth, MS10*, Patrick Kaminker, PhD10*, Paul Moore, PhD10* and Bradley James Sumrow, MD10*

1Duke Cancer Institute, Durham, NC
2Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK
3Department of Haematology, St Vincent's Hospital, Sydney, Australia
4Austin Health, Olivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australia
5BioVirtus, Jozefow, Poland
6Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
7Regional Treatment and Diagnostics Haematology Centre, Department of Hematology, Cherkasy Regional Oncology Centre, Cherkasy, Ukraine
8Banner MD Anderson Cancer Center, Gilbert, AZ
9University of Oklahoma Health Sciences Center, Oklahoma City, OK
10MacroGenics, Inc., Rockville, MD
11MacroGenics, Inc., Brisbane, CA

Sophie Bernard1*, Hervé Ghesquieres, MD, PhD2*, Rene-Olivier Casasnovas, MD3,4*, Maria Gomes Da Silva, MD, PhD5*, Pierre Feugier, MD, PhD6*, Franck Morschhauser, MD, PhD7*, Judith Trotman, FRACP8, Richard Greil, MD9, Dolores Caballero, MD, PhD10, Sebastian Grosicki, MD, PhD11, Koen Van Eygen, MD12*, Christiane Copie, MD PhD13*, Corinne Haioun, MD PhD14 and Catherine Thieblemont, MD, PhD15

1Assistance Publique Hôpitaux de Paris - Hopital Saint-Louis, Paris, Paris, France
2Department of Hematology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre Benite, France
3Hématologie Clinique and INSERM 1231, CHU Dijon, Dijon, France
4Inserm UMR 1231, Dijon, France
5IPO, Lisboa, Portugal
6Hematology Department, Nancy University Hospital, Vandoeuvre-lès-Nancy, France
7Clinical Hematology Department, Centre Hospitalier Régional Universitaire de Lille, Lille, France
8Haematology, Concord Repatriation General Hospital, University of Sydney, Concord, Australia
9Salzburg Cancer Research Institute CCCIT, Cancer Cluster Salzburg, Paracelsus Medical University Salzburg, Salzburg, Austria
10Hospital Universitario de Salamanca, Salamanca, Spain
11Department of Hematology and Cancer Prevention, Medical University of Silesia, Katowice, Poland
12Algemeen Ziekenhuis Groeninge, Kortrijk, Belgium
13Department of Pathology, CHU Henri Mondor, AP HP, Paris, France
14Lymphoid Malignancies, Henri Mondor Hospital, Creteil, France
15APHP, Hôpital Saint-Louis, Hémato-oncologie, Université de Paris, Paris Diderot, Paris, France

Peter Hillmen, MBChB, PhD, FRCP, FRCPath1, Hope Qamoos, CNP2*, Anne Uyei, MD2*, Wayne M. Rothbaum2*, Wojciech Jurczak, MD, PhD3, Catherine Thieblemont, MD, PhD4 and John C. Byrd, MD5

1St. James's University Hospital, Leeds, United Kingdom
2Kartos Therapeutics, Inc., Redwood City, CA
3Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Poland
4Hôpital Saint-Louis, Paris, France
5The James - Ohio State University, Columbus, OH

Jillian Simard, MD1, Christopher Melani, MD2, Rahul Lakhotia, MD1, Michail S. Lionakis, MD, ScD3*, Stefania Pittaluga, MD, PhD4, James D. Phelan, PhD1*, Jagan R. Muppidi, MD, PhD1*, Lydia L. Chou, CRNP1*, Matthias Holdhoff, MD, PhD5*, Michael Glantz, MD, PhD6*, John A. Butman, MD, PhD7*, Andrea Nicole Lucas, RN1*, Seth M. Steinberg, PhD8*, Elaine S. Jaffe, MD4, Louis M. Staudt, MD, PhD1, Wyndham H. Wilson, MD, PhD1 and Mark Roschewski, MD9

1Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
2Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Baltimore, MD
3Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD
4Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD
5Department of Neuro-Oncology, Johns Hopkins Cancer Center, Baltimore, MD
6Department of Neurosurgery, Penn State College of Medicine, Hershey, PA
7Radiology and Imaging Sciences, Clinical Center, National Cancer Institute, National Institutes of Health, Bethesda, MD
8Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD
9Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD

Colin Phipps, MD1,2*, Chandramouli Nagarajan, MBBS1*, Lawrence Ng, MBBS1*, Jane L Chua1*, Yunxin Chen, MBBS1*, Shin Yeu Ong, MD1*, Melinda Si Yun Tan, MBBS1*, Nicholas Francis Grigoropoulos, MD, PhD1*, Sathish Gopalakrishnan, MD1,3*, Heng Joo Ng, MBBS1*, William YK Hwang, MBBS1,4, Yeow Tee Goh, MBBS1 and Yuh Shan Lee, MBBS1,2*

1Department of Hematology, Singapore General Hospital, Singapore, Singapore
2Parkway Cancer Centre, Singapore, Singapore
3Hematology, Northeast Cancer Centre, Sudbury, Canada
4National Cancer Center Singapore, Singapore, Singapore

Ulrich Jaeger, MD1,2, Alexander Egle, MD3, Ingrid Simonitsch-Klupp, MD4*, Sonja Heibl, MD5*, Peter Neumeister, MD6*, Ella Willenbacher, MD7, Florian Erlsbacher8*, Julian Larcher-Senn8*, Michael A. Fridrik, MD9 and Richard Greil, MD2,3

1Department of Medicine I, Division of Hematology and Hemostaseology, and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
2Austrian Group Medical Tumor Therapy, Salzburg, Austria
3Department of Internal Medicine III with Hematology, Medical Oncology, Hemostaseology, Infectiology and Rheumatology, Oncologic Center, Salzburg Cancer Research Institute-Laboratory for Immunological and Molecular Cancer Research (SCRI-LIMCR), Paracelsus Medical University, Cancer Cluster Salzburg, Salzburg, Austria
4Department of Pathology, Medical University of Vienna, Vienna, Austria
5Dept. of Internal Medicine IV, Klinikum Wels-Grieskirchen GmbH, Wels, Austria
6Department of Internal Medicine, Division of Hematology, Medical University of Graz, Graz, Austria
7Department of Internal Medicine V, Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria
8Assign Data Management and Biostatistics GmbH, Innsbruck, Austria
9Department of Hematology and Oncology, Kepler University Hospital, Johannes Kepler University, Linz, Austria

David Belada, MD, PhD1*, Grzegorz S. Nowakowski, MD2, Juan Miguel Bergua Burgues, MD3*, Marc André, MD4*, Katerina Kopeckova, MD5*, Don A. Stevens, MD6, Marek Trněný, MD, Prof7, Ernesto Pérez Persona8*, Petra Pichler9*, Pia Klöpfer10*, Bettina Brackertz10*, Emanuel Lohrmann, MD10*, Anirban Lahiry10*, Neha Shah10*, Günter Fingerle-Rowson, MD, PhD10, Wolfram Brugger10* and John M. Burke, MD11

14th Department of Internal Medicine – Hematology, University, Hospital and Faculty of Medicine, Hradec Králové, Czech Republic
2Division of Hematology, Mayo Clinic, Rochester, MN
3Hematology, Hospital San Pedro Alcántara, Caceres, Spain
4Department of Haematology, Université Catholique de Louvain, CHU UCL Namur, Yvoir, Belgium
5Fakultni nemocnice v Motole, Prague, Czech Republic
6Norton Cancer Institute - St Matthews Campus, Louisville, KY
71st Dept. of Internal Medicine, First Medical Faculty, Charles University and General University Hospital, Prague, Czech Republic
8Hospital Universitario Araba, Txagorritxu, Spain
99Department of Internal Medicine, University Hospital of St Pölten, Karl Landsteiner University of Health Sciences, Karl Landsteiner Institute for Nephrology and Hemato Oncology, St Pölten, Austria
10MorphoSys AG, Planegg, Germany
11US Oncology Hematology Research Program, US Oncology Research and Rocky Mountain Cancer Centers, Aurora, CO

Tae Min Kim, MD, PhD1*, Arancha Alonso, MD2*, Miles Prince, MD3, Michal Taszner, MD4*, Seok-Goo Cho, M.D., Ph.D.5*, Don A. Stevens, MD6, Michelle Poon, MD7*, Francesca Lim, MBBS, BSc, MRCP (UK)8*, Steven Le Gouill, MD, PhD9, Cecilia Carpio, MD10,11*, Mary-Margaret Keating, MD, FRCPC12, Lieve Adriaens, PharmD13*, Melanie Ufkin, PhD13, Ayesha Sabir, BSc13*, Jingjin Li, PhD13*, Vladimir Jankovic, MD13, Min Zhu, PhD13*, Jurriaan Brouwer-Visser, PhD13*, Siyang Leng, MD, MS13*, L. Andres Sirulnik, MD, PhD13, Aafia Chaudhry, MD, MBA, MS13*, Srikanth R. Ambati, MBBS, MD13* and Kim Won Seog, MD, PhD14*

1Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of (South)
2Hospital Universitario Quirón Salud, Madrid, Spain
3Cancer Immunology and Molecular Oncology, Epworth Healthcare, University of Melbourne, Melbourne, Australia
4Hematology and Bone Marrow Transplantation Department, University of Gdańsk, Gdańsk, Poland
5Department of Hematology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea, Republic of (South)
6Norton Health Care, Louisville, KY
7Department of Haematology-Oncology, National University Hospital, Singapore, Singapore
8Department of Haematology, Singapore General Hospital, Singapore, Singapore
9Service d'hématologie clinique, CHU de Nantes, Nantes, France
10Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
11Departament de Medicina, Universitat Autònoma de Barcelona, Barcelona, Spain
12Dalhousie University, Halifax, NS, Canada
13Regeneron Pharmaceuticals, Inc., Tarrytown, NY
14Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)

Nirav N. Shah, MD1, Ahmad H. Mattour, MD2, Leslie L. Popplewell, MD, FACP3, Charalambos Andreadis, MD4, Jason M. Melear, MD5, Alexander I. Spira, PhD, MD, FACP6*, Jonah Shulman, MD7*, Sudhir Manda, MD8, John M. Burke, MD9, Saurabh Chhabra, MD, MS1, Jeff P Sharman, MD10, Amrita Krishnan, MD3, Nina Shah, MD11, Clifford DiLea, RPh, Pharm.D.12*, Jason Kuriakose, MBA13*, Craig Jerome Berman, MD13*, Shannon L. Matheny, PhD13*, John P. Leonard, MD14 and Arturo Molina, MD, MS13

1Medical College of Wisconsin, Milwaukee, WI
2Henry Ford Health System, Detroit, MI
3City of Hope, Duarte, CA
4University of California, San Francisco, San Francisco, CA
5Texas Oncology, Austin, TX
6Virginia Cancer Specialists, Fairfax, VA
7Icahn School of Medicine at Mount Sinai, New York, NY
8Arizona Oncology/US Oncology Research, Tucson, AZ
9Rocky Mountain Cancer Centers, Aurora, CO
10Willamette Valley Cancer Institute and Research Center, Eugene, OR
11Associate Professor of Medicine, University of California San Francisco, San Francisco, CA
12Aclairo Pharmaceutical Development Group, Inc., Vienna, VA
13Sutro Biopharma, South San Francisco, CA
14Weill Cornell Medicine and New York Presbyterian Hospital, New York, NY

Reem Karmali, MD, MSc1, Jeremy S Abramson, MD, MMSc2, Deborah M. Stephens, DO3, Jeffrey A Barnes, MD, PhD2, Jason Kaplan, MD4, Jane N. Winter, MD5, Shuo Ma, MD, PhD6, Juehua Gao, MD, PhD7*, Adam M Petrich, MD8,9, Ephraim Hochberg, MD2, Ronald Takvorian10*, Frank Kuhr, PhD11*, Valerie Nelson, MD, MBA6*, Leo I. Gordon, MD6 and Barbara Pro, MD12

1Robert H. Lurie Comprehensive Cancer Center, Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL
2Massachusetts General Hospital Cancer Center, Boston, MA
3University of Utah/Huntsman Cancer Institute, Salt Lake City, UT
4Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
5Division of Hematology and Oncology, Northwestern University, Chicago, IL
6Division of Hematology and Oncology, Northwestern University Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
7Department of Pathology, Northwestern University, Chicago, IL
8Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
9Daiichi-Sankyo, Inc., Basking Ridge, NJ
10Massachusetts General Hospital, Harvard Medical School, Boston, MA
11Adaptive Biotechnologies, Seattle, WA
12Division of Hematology and Oncology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL

Lorenz Thurner, MD1*, Viola Poeschel, MD2*, Bettina Altmann, PhD3*, Herve Tilly, MD, PhD4, Marc Andre, MD5*, Marie Maerevoet, MD6*, Thomas Weber, MD7*, Joerg Hoffmann, MD8*, Martin Dreyling, MD9, Herve Maisonneuve, MD10, Andrea Kerkhoff, MD11*, Steven Le Gouill, MD, PhD12, Stephan Stilgenbauer, MD13, Marita Ziepert, PhD3*, Roch Houot, MD, PhD14*, Corinne Haioun, MD PhD15 and Gerhard Held, MD16*

1Department of Hematology, Oncology, Rheumatology and Clinical Immunology, Saarland University Medical Center, Homburg, Germany
2Department of hematology, oncology and rheumatology, Saarland University Medical School, Homburg/Saar, Germany
3Institute for Medical Informatics, Statistics and Epidemiology, University Leipzig, IMISE, Leipzig, Germany
4Centre Henri Becquerel, Rouen, France
5Hematology Department, Hopital Charleroi, Charleroi, BEL
6Department of Hematology, Institut Jules Bordet (ULB), Brussels, Belgium
7Department of Medicine IV, Hematology and Oncology, University Hospital Halle, Halle, DEU
8Hämatologie, Onkologie und Immunologie, Philipps Universität Marburg, Marburg, Germany
9Department of Medicine III, Klinikum Der Universitaet Muenchen-Campus Grosshadern, Munich, Germany
10Clinical Hematology, Centre Hospitalier Départemental Vendée, La Roche-sur-Yon, France
11Department of Medicine A, University Hospital Muenster, Muenster, Germany
12Service d'hématologie clinique, CHU de Nantes, Nantes, France
13Department of Internal Medicine I, Saarland University Medical School, Homburg, Germany
14Hematology Department, CHU Rennes, Rennes, France
15Clinical Hematology, Henri Mondor University Hospital, UPEC, Creteil, France
16Department for hematology and oncology, Westpfalz-Klinikum Kaiserslautern, Kaiserslautern, Germany

Karin Fjorden1*, Sara Ekberg2*, Nevzeta Kuric3*, Karin Ekstroem Smedby4*, Ingemar Lagerlöf, MD5*, Thomas S. Larsen, MD6*, Judit M. Jørgensen, MD, PhD7*, Peter de Nully Brown, MD, PhD8* and Mats Jerkeman, MD, PhD1

1Department of Oncology, Lund University and Skane University Hospital, Lund, Sweden
2Division of Clinical Epidemiology, Dept of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
3Department of Hematology, Halmstad Hospital, Halmstad, Sweden
4Department of Medicine, Solna, Division of Hematology, Karolinska Institute and Karolinska University Hospital, Stockholm, Stockholm, Sweden
5Division of Drug Research, Department of Medical and Health Sciences, Linköping University, Linköping, Sweden
6Department of Hematology, Odense University Hospital, Odense, Denmark
7Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
8Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Neil Bailey, MSc1*, Tenzin Tsomo, BS1*, Jennie Szeto, BA1*, William I Bensinger, MD1*, Daniel Egan, MD2*, Livia Hegerova, MD2*, Raya Mawad, MD3*, Ami Batchelder, PA2*, Joanna Fesler, ARNP1*, Heather Holdread, MS, NP2*, Sonia Glennie, ARNP1*, Judson Hall, ARNP2*, Joey Ferry, ARNP2*, Megumi Bailey, MSc4*, David Kane, RN2*, John M. Pagel, MD PhD1 and Krish Patel, MD1

1Center for Blood Disorders and Stem Cell Transplantation, Swedish Cancer Institute, Seattle, WA
2Swedish Medical Center, seattle
3Swedish Cancer Institute, Seattle, WA
4Swedish Medical Center, Seattle, WA

*signifies non-member of ASH